Halozyme Therapeutics Comprehensive Income 2010-2024 | HALO
- Halozyme Therapeutics comprehensive income for 2023 was $-0.009B, a 906.29% increase from 2022.
- Halozyme Therapeutics comprehensive income for 2022 was $-0.001B, a 48.71% increase from 2021.
- Halozyme Therapeutics comprehensive income for 2021 was $-0.001B, a 2918.18% decline from 2020.